medicina61巻1号

2024年01月発行

特集 その知見は臨床を変える?—エキスパートが解説! 内科における最新論文 呼吸器

過敏性肺炎に関する最新のトピックス

著者： 飯島裕基¹

所属機関： ¹東京医科歯科大学呼吸器内科

ページ範囲：P.30 - P.36

Point
◎予後の観点から，病型分類が急性・慢性から線維性・非線維性へ変更された．
◎抗原曝露歴，気管支肺胞洗浄液（BALF）所見，画像所見，病理所見などから総合的に診断する．
◎抗原回避が最重要だが，改善しない症例に対してはステロイドや抗線維化薬が用いられる．

参考文献

1）Costabel U, et al：Hypersensitivity pneumonitis. Nat Rev Dis Primers 6：65, 2020 PMID 32764620

2）Raghu G, et al：Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 202：e36-e69, 2020 PMID 32706311

3）日本呼吸器学会過敏性肺炎診療指針2022作成委員会（編）：過敏性肺炎診療指針2022，日本呼吸器学会，2022

4）Ando M, et al：Japanese summer-type hypersensitivity pneumonitis. Geographic distribution, home environment, and clinical characteristics of 621 cases. Am Rev Respir Dis 144：765-769, 1991 PMID 1928946

5）Okamoto T, et al：Nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan. Respir Investig 51：191-199, 2013 PMID 23978646

6）Ohnishi H, et al：Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis. BMC Pulm Med 14：129, 2014 PMID 25098177

7）Okamoto T, et al：Seasonal variation of serum KL-6 and SP-D levels in bird-related hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis 31： 364-367, 2015 PMID 2591150

8）Ryerson CJ, et al：A standardized diagnostic ontology for fibrotic interstitial lung disease. An international working group perspective. Am J Respir Crit Care Med 196：1249-1254, 2017 PMID 28414524

9）Fernández Pérez ER, et al：Diagnosis and evaluation of hypersensitivity pneumonitis；CHEST guideline and expert panel report. Chest 160：e97-e156, 2021 PMID 33861992

10）Vasakova M, et al：Hypersensitivity pneumonitis；Perspectives in diagnosis and management. Am J Respir Crit Care Med 196：680-689, 2017 PMID 28598197

11）Tsutsui T, et al：Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis. Respir Investig 53：217-224, 2015 PMID 26344611

12）Barnett J, et al：Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Eur Respir J 54：1900531, 2019 PMID 31164428

13）Takemura T, et al：Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 61：1026-1035, 2012 PMID 22882269

14）Fernández Pérez ER, et al：Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest 144：1644-1651, 2013 PMID 23828161

15）Petnak T, et al：Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis. Eur Respir J 60：2101336, 2022 PMID 35236720

16）Wells AU, et al：Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial；A randomised, double-blind, placebo-controlled, parallel-group trial. The Lancet Respiratory Medicine 8：453-460, 2020 PMID 32145830